Samsung Medical Center
Seoul, 06351, South Korea
NCT Number: NCT06115031
The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anesthesia (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seoul, 06351, South Korea
Remimazolam, a short-acting benzodiazepine, has recently gained approval for use in the induction and maintenance of general anesthesia. In American Society of Anesthesiologists (ASA) physical status class I and II patients undergoing general anesthesia, the remimazolam-based TIVA has shown comparable efficacy to propofol-based TIVA while demonstrating a superior safety profile. Remimazolam has exhibited a lower incidence of hypotension, reduced vasopressor requirements, and fewer instances of bradycardia compared to the propofol-based TIVA.
The use of benzodiazepine has been associated with an increased risk of postoperative delirium, but there is currently no randomized controlled trial investigating the relationship between remimazolam, a new short-acting benzodiazepine, and postoperative delirium. Therefore, the investigators designed this prospective, randomized, double-blinded, active comparator-controlled, non-inferiority trial to investigate the incidence of postoperative delirium after remimazolam-based TIVA compared with propofol-based TIVA in neurosurgery patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
General anesthesia will be induced and maintained using continuous infusion of intravenous remimazolam.
Other names: byfavo inj
General anesthesia will be induced and maintained using target-controlled infusion of intravenous propofol.
Other names: Fresofol
Time frame: assessed up to postoperative day 5 or patient discharge, whichever came first
The occurrence of postoperative delirium, defined as at least one positive assessment during the postoperative period. Delirium will be assessed twice a day using confusion assessment method for the intensive care unit (CAM-ICU) and 3-minute diagnostic assessment for CAM-defined delirium (3D-CAM).
These are binary diagnostic instruments (delirium present vs absent), not scored scales.
Time frame: from the end of surgery to the postoperative day 5
Duration is quantified as the cumulative number of positive CAM-ICU or 3D-CAM assessments (protocol secondary outcome: number of positive delirium assessment) collected twice daily.
Time frame: assessed twice a day up to postoperative day 5 or patient discharge, whichever came first
Hypoactive/hyperactive/mixed
Time frame: assessed twice a day up to postoperative day 5 or patient discharge, whichever came first
Severity of postoperative delirium will be assessed twice a day using DRS-R-98 (delirium rating scale-revised-98); total score range 0-46; higher scores = more severe delirium.
Time frame: within 30 min after extubation
Incidence of emergence agitation, defined as Richmond Agitation-Sedation Scale (RASS) ≥+1 within 30 minutes after extubation. RASS ranges from -5 to +4; higher scores indicate greater agitation. The outcome is binary (emergence agitation present vs absent).
Time frame: Up to 1 hour after surgery
Percentage of the patients who were not extubated in the OR and transferred to the ICU, delayed extubation (> 1 h after surgery completion)
Time frame: at postoperative day 0
Intraoperative awareness will be assessed using Modified Brice questionnaire; binary outcome, not a scored scale.
Time frame: During surgery
Undesirable movement of patient during surgery
Time frame: During surgery
bradycardia with the use of chronotropic agent, laryngeal spasm, bronchospasm, allergic reaction, arrhythmia, cardiac events (myocardial infarction, vasospasm, or cardiac arrest), or massive bleeding
Time frame: During surgery
Intraoperative hypotension, quantified as the area under the mean arterial pressure threshold of 65 mm Hg. (Unit: mm Hg·min)
Time frame: postoperative day 1
Quality of Recovery-15 (QoR-15); score range 0-150; higher = better recovery.
Time frame: Up to 30 days after surgery
assessed by Clavien-Dindo classification Data are presented as the proportion of patients with 1 or more events (edema, vasospasm, rebleeding, seizures, and/or ischemia, etc.)
Time frame: from the day of surgery to the time of patient discharge from ICU, assessed up to 3 months after surgery
days
Time frame: from the day of surgery to the time of patient discharge, assessed up to 3 months after surgery
days
Time frame: 3-months after surgery
the incidence of postoperative falls and associated injury (presence of fracture)
Time frame: postoperative day 7, 3-months after surgery
Changes in cognition assessed by Montreal Cognitive Assessment (MoCA) at baseline and postoperative day 7 (or discharge, whichever comes first); range 0-30; higher = better cognition. And by telephone-MoCA (T-MoCA) at 3 months;range 0-22; higher = better cognition.
Time frame: 3-months after surgery
assessed using Barthel activity of daily living (ADL) index
; score range 0-20; higher = greater independence.
Time frame: Up to 3 days (72 hours) after surgery
PONV sub-study is a pre-planned non-inferiority sub-study for this main trial. Number (percentage) of participants with nausea and/or vomiting, assessed in participants enrolled in the PONV sub-study.
Time frame: Up to 3 days (72 hours) after surgery
Severity of postoperative nausea and vomiting, assessed using the PONV Intensity Scale in participants enrolled in the PONV sub-study. Higher scores indicate more severe PONV.
Time frame: Up to 3 days (72 hours) after surgery
Number (percentage) of participants who received rescue anti-emetic medication in the PONV sub-study.
Time frame: assessed up to postoperative day 5 or patient discharge, whichever came first
Subgroup analysis (age, sex, surgery type, preoperative cognitive impairment, ASA physical status, duration of anesthesia, alcohol abuse, or chronic benzodiazepine use)
Time frame: During surgery
Relative spectral power in the alpha, beta, delta, and theta frequency bands, derived from intraoperative electroencephalography (EEG).
Time frame: During surgery
Phase-amplitude coupling between EEG frequency bands, derived from intraoperative EEG.
Samsung Medical Center
Other
Effect of Remimazolam Versus Propofol Anesthesia on Postoperative Delirium in Neurosurgical Patients: A Randomised, Controlled, Noninferiority Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05823844
Confusion, Delirium
New York, United States
View Trial DetailsNCT07714928
Cognition Disorders, Cognitive Dysfunction
Örebro, Sweden
View Trial DetailsNCT05574400
Alzheimer Disease, Brain Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT03606941
Confusion, Delirium
Tianjin, Tianjin Municipality, China
View Trial Details